CB Therapeutics
YC S18 ↗San Diego, US · Founded 2015 · Incorporated in Cayman Islands · 18 employees · 4 known investors
CB Therapeutics builds a yeast platform for biosynthesis of molecules including psychedelics, cannabis, and alkaloids that are difficult to source through conventional methods. The company serves pharmaceutical and specialty chemical manufacturers.
AI & Machine LearningBiotechDeep TechHealthtechCellular Agriculturein /6455436@ycombinatorycombinator.com ↗
Founders & leadership· Y Combinator alumni (S18)
SB
Sher ButtinFounder/CEO
JV
Jacob VoganinFounder
BZ
Bing ZhuResignation effective upon this financing.
SR
Sanjeev RedkarAppointment effective upon this financing.
AW
Alex WuResignation effective upon this financing.
JW
Jonathan WangAppointment effective upon this financing.
GY
Guoliang YuExecutive Officer, Director
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$4MraisedAug 2016 · 3 investors · Other Health CareRule 506(b)
▶$4MraisedAug 2016 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bing ZhuExecutive Officer
- Sanjeev RedkarExecutive Officer, Director
- Alex WuDirector
- Jonathan WangDirector
- Guoliang YuExecutive Officer, Director
- Offering amount
- $7.8M
- Amount sold
- $4M
- First sale
- Jul 2016
- Incorporated
- Other, Cayman Islands, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- CB Therapeutics Secures $395M | Signalbasetrysignalbase.com · 2026
- CB Therapeutics on Republic 2023 - Kingscrowdkingscrowd.com · 2023
- CB Therapeutics and atai Life Sciences launch TryptageniXglobenewswire.com · 2022
- CB Therapeutics Closes Series A Funding - FinSMEsfinsmes.com · 2021
- CB Therapeutics Closes on Oversubscribed Series A - BioSpacebiospace.com · 2021
